Veradigm Quick Ratio 2010-2022 | MDRX
Historical quick ratio values for Veradigm (MDRX) over the last 10 years.
| Veradigm Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2022-12-31 | $0.00B | $0.23B | 0.00 |
| 2022-09-30 | $0.00B | $0.25B | 0.00 |
| 2022-06-30 | $0.00B | $0.26B | 0.00 |
| 2022-03-31 | $0.00B | $0.65B | 0.00 |
| 2021-12-31 | $0.00B | $0.49B | 0.00 |
| 2021-09-30 | $0.00B | $0.57B | 0.00 |
| 2021-06-30 | $0.00B | $0.60B | 0.00 |
| 2021-03-31 | $0.00B | $0.88B | 0.00 |
| 2020-12-31 | $0.00B | $0.94B | 0.00 |
| 2020-09-30 | $0.00B | $0.75B | 0.00 |
| 2020-06-30 | $0.00B | $1.11B | 0.00 |
| 2020-03-31 | $0.00B | $1.16B | 0.00 |
| 2019-12-31 | $0.00B | $1.21B | 0.00 |
| 2019-09-30 | $0.00B | $1.18B | 0.00 |
| 2019-06-30 | $0.00B | $0.88B | 0.00 |
| 2019-03-31 | $0.00B | $0.80B | 0.00 |
| 2018-12-31 | $0.00B | $0.80B | 0.00 |
| 2018-09-30 | $0.00B | $0.89B | 0.00 |
| 2018-06-30 | $0.00B | $0.91B | 0.00 |
| 2018-03-31 | $0.00B | $0.89B | 0.00 |
| 2017-12-31 | $0.00B | $0.89B | 0.00 |
| 2017-09-30 | $0.00B | $0.68B | 0.00 |
| 2017-06-30 | $0.00B | $0.67B | 0.00 |
| 2017-03-31 | $0.00B | $0.70B | 0.00 |
| 2016-12-31 | $0.00B | $0.67B | 0.00 |
| 2016-09-30 | $0.00B | $0.63B | 0.00 |
| 2016-06-30 | $0.00B | $0.61B | 0.00 |
| 2016-03-31 | $0.00B | $0.54B | 0.00 |
| 2015-12-31 | $0.00B | $0.51B | 0.00 |
| 2015-09-30 | $0.00B | $0.49B | 0.00 |
| 2015-06-30 | $0.00B | $0.52B | 0.00 |
| 2015-03-31 | $0.00B | $0.54B | 0.00 |
| 2014-12-31 | $0.00B | $0.52B | 0.00 |
| 2014-09-30 | $0.00B | $0.52B | 0.00 |
| 2014-06-30 | $0.00B | $0.52B | 0.00 |
| 2014-03-31 | $0.00B | $0.53B | 0.00 |
| 2013-12-31 | $0.00B | $0.52B | 0.00 |
| 2013-09-30 | $0.00B | $0.52B | 0.00 |
| 2013-06-30 | $0.00B | $0.54B | 0.00 |
| 2013-03-31 | $0.00B | $0.63B | 0.00 |
| 2012-12-31 | $0.00B | $0.52B | 0.00 |
| 2012-09-30 | $0.63B | $0.54B | 1.17 |
| 2012-06-30 | $0.65B | $0.56B | 1.16 |
| 2012-03-31 | $0.72B | $0.56B | 1.29 |
| 2011-12-31 | $0.00B | $0.50B | 0.00 |
| 2011-09-30 | $0.59B | $0.46B | 1.28 |
| 2011-06-30 | $0.61B | $0.49B | 1.24 |
| 2011-03-31 | $0.60B | $0.45B | 1.32 |
| 2010-12-31 | $0.57B | $0.43B | 1.33 |
| 2010-09-30 | $0.55B | $0.39B | 1.42 |
| 2010-06-30 | $0.00B | 0.00 | |
| 2010-05-31 | $0.41B | $0.21B | 1.91 |
| 2010-03-31 | $0.00B | 0.00 | |
| 2010-02-28 | $0.34B | $0.19B | 1.80 |
| 2009-12-31 | $0.29B | $0.16B | 1.84 |
| 2009-11-30 | $0.29B | $0.16B | 1.82 |
| 2009-09-30 | $0.00B | 0.00 | |
| 2009-08-31 | $0.27B | $0.16B | 1.73 |
| 2009-05-31 | $0.26B | $0.16B | 1.57 |
| 2009-02-28 | $0.28B | $0.17B | 1.63 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.525B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.456B | 59.10 |
| Doximity (DOCS) | United States | $11.587B | 53.64 |
| Hims & Hers Health (HIMS) | United States | $10.739B | 111.58 |
| Tempus AI (TEM) | United States | $10.555B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.548B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.789B | 59.21 |
| Hinge Health (HNGE) | United States | $3.638B | 0.00 |
| Privia Health (PRVA) | United States | $2.696B | 184.25 |
| Enovis (ENOV) | United States | $1.922B | 10.72 |
| Phreesia (PHR) | United States | $1.725B | 0.00 |
| 10x Genomics (TXG) | United States | $1.602B | 0.00 |
| Schrodinger (SDGR) | United States | $1.550B | 0.00 |
| Azenta (AZTA) | United States | $1.521B | 70.70 |
| Omnicell (OMCL) | United States | $1.398B | 24.66 |
| Evolent Health (EVH) | United States | $1.384B | 117.90 |
| Clover Health Investments (CLOV) | United States | $1.303B | 0.00 |
| Claritev (CTEV) | United States | $0.747B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.611B | 0.00 |
| Standard BioTools (LAB) | United States | $0.513B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.480B | 0.00 |
| Talkspace (TALK) | United States | $0.463B | 138.50 |
| Outset Medical (OM) | United States | $0.370B | 0.00 |
| TruBridge (TBRG) | United States | $0.343B | 761.67 |
| Health Catalyst (HCAT) | United States | $0.283B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.265B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.199B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.167B | 0.00 |
| American Well (AMWL) | United States | $0.133B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.126B | 0.00 |
| Pulmonx (LUNG) | United States | $0.112B | 0.00 |
| CareCloud (CCLD) | United States | $0.104B | 3.97 |
| MDxHealth SA (MDXH) | Belgium | $0.104B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.082B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| HeartBeam (BEAT) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.018B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |